Prev Arrow Stocks

HCA Healthcare Inc. ($HCA) Stock Forecast: Up 6.6% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is HCA Healthcare Inc.?

HCA Healthcare (NYSE: HCA) is a leading healthcare services provider, offering a wide range of medical services across the United States. The company has been experiencing a bullish market movement today, with its stock price up 4.4%.

Why is HCA Healthcare Inc. going up?

HCA stock is up 6.6% on Feb 11, 2026 19:46

  • Unusual options activity on HCA Healthcare, with predominantly bullish trades and a price window of $350.0 to $560.0, signals a positive sentiment among investors, propelling the stock price higher.
  • The reduction in stake by Prospera Financial Services Inc. may have initially raised concerns, but increased positions by other institutional investors and robust quarterly earnings report surpassing EPS estimates and raising dividends have reassured investors and fueled the bullish trend.
  • The upcoming community meetings to discuss updates on HCA Mission Health System could be viewed as a favorable move towards transparency and accountability, potentially enhancing investor confidence in HCA Healthcare's operations and future outlook.

HCA Price Chart

HCA Technical Analysis

HCA News

Apple Just Paid Investors And This Is AAPL’s Dividend Grade

Apple (AAPL) recently paid a quarterly dividend of $0.26 per share, maintaining an A- dividend grade due to strong coverage ratios and cash generation, despite a yield below market averages. The company prioritizes capital appreciation and share buybacks, with a 13.06% payout ratio and substantial operating cash flow ensuring dividend safety and growth potential for long-term investors. While its yield is low, Apple's significant stock performance and robust financials make its dividend secure and suitable for growth-oriented portfolios.

https://247wallst.com/investing/2026/02/11/apple-just-paid-investors-and-this-is-aapls-dividend-grade/

0 News Article Image Apple Just Paid Investors And This Is AAPL’s Dividend Grade

HCA Healthcare Unusual Options Activity For February 11

Investors have shown significant bullish interest in HCA Healthcare (NYSE: HCA) through unusual options activity, with 9 uncommon trades identified, predominantly bullish. The options activity suggests a price window of $350.0 to $560.0, and the stock is currently trading at $502.05, up 4.4%. Market experts have a consensus target price of $536.0 for HCA Healthcare.

https://www.benzinga.com/insights/options/26/02/50550277/hca-healthcare-unusual-options-activity-for-february-11

1 News Article Image HCA Healthcare Unusual Options Activity For February 11

HCA Healthcare, Inc. $HCA Stake Lessened by Prospera Financial Services Inc

Prospera Financial Services Inc. has reduced its stake in HCA Healthcare by 19.5% during the third quarter, selling 3,240 shares. Despite this reduction, other large institutional investors, including Norges Bank, Pacer Advisors Inc., and Viking Global Investors LP, have increased their positions in HCA, pushing institutional ownership to 62.73%. HCA Healthcare also reported strong quarterly earnings, beating EPS estimates, issuing optimistic FY2026 guidance, and raising its quarterly dividend.

https://www.marketbeat.com/instant-alerts/filing-hca-healthcare-inc-hca-stake-lessened-by-prospera-financial-services-inc-2026-02-11/

2 News Article Image HCA Healthcare, Inc. $HCA Stake Lessened by Prospera Financial Services Inc

Baader Bank Aktiengesellschaft Sells 8,794 Shares of ResMed Inc. $RMD

Baader Bank Aktiengesellschaft significantly reduced its stake in ResMed Inc. by selling 8,794 shares, lowering its holdings to 10,417 shares valued at $2.82 million. This comes as ResMed outperformed quarterly expectations with strong EPS and revenue growth, and analysts maintain a "Moderate Buy" rating with a consensus target price of $299.27. Despite institutional buying, company insiders have recently sold over $4.6 million in shares.

https://www.marketbeat.com/instant-alerts/filing-baader-bank-aktiengesellschaft-sells-8794-shares-of-resmed-inc-rmd-2026-02-11/

3 News Article Image Baader Bank Aktiengesellschaft Sells 8,794 Shares of ResMed Inc. $RMD

Meetings planned to hear latest on HCA Mission Health

Dogwood Health Trust and Affiliated Monitors, Inc. have announced upcoming community meetings in March to share updates about the Independent Monitor's work regarding HCA Mission Health System. These meetings will review findings from the 2025 reporting year and outline the process for the 2026 report, providing a platform for community members to voice concerns. Attendees are encouraged to register in advance for the in-person meetings in Transylvania County and Asheville, with the Asheville meeting also being livestreamed.

https://www.transylvaniatimes.com/news/meetings-planned-to-hear-latest-on-hca-mission-health/article_13ee48eb-e35c-4062-9999-ecc6c1f57077.html

4 News Article Image Meetings planned to hear latest on HCA Mission Health

HCA Healthcare Inc. Price History

05.00.2026 - HCA Stock was up 1.7%

  • HCA Healthcare's stock rallied steadily due to strong fundamentals, consistent guidance, and a focus on returning cash to shareholders, attracting investor attention away from tech giants.
  • The reduction in stake by Gateway Investment Advisers LLC and an EVP could indicate profit-taking after strong Q3 earnings and price target upgrades, contributing to the stock's positive momentum.
  • The adoption of advanced robotics for orthopedic surgeries at Marion County HCA Hospitals showcases HCA's commitment to innovation and improving patient outcomes, potentially boosting investor confidence in the company's growth prospects.
  • Despite a lower P/E ratio compared to the broader market, investors remain cautious about HCA Healthcare's future earnings volatility or potential threats, reflecting a sense of uncertainty despite the positive market outlook.

25.03.2025 - HCA Stock was down 5.2%

  • Following robust financial performance in Q1 where revenue and adjusted EPS surpassed expectations, HCA Healthcare witnessed a decline in its stock price.
  • Despite the positive earnings and revenue results, broader market trends and investor sentiment outweighed the strong performance.
  • The general optimism in the market, evident in the rise of US futures and consecutive gains on Wall Street, likely influenced profit-taking activities in HCA Healthcare's stock.
  • Investor response to market volatility and fluctuating trade setups could have driven the bearish movement in HCA stock, despite its favorable financial outlook.

09.05.2025 - HCA Stock was down 0.2%

  • The bearish movement in HCA stock today could be attributed to profit-taking by investors after a prolonged period of growth.
  • The long-term investment potential of HCA may have led some investors to reassess their short-term positions, contributing to the bearish movement.
  • Market volatility and broader economic factors may have also played a role in the downward movement of HCA stock today.

16.05.2025 - HCA Stock was down 4.1%

  • Despite a bullish stance from investors with significant capital, HCA Healthcare experienced a strong bearish movement in the stock market today.
  • The discrepancy between the bullish options trading activity and the bearish stock movement could indicate a divergence in market sentiment and actual performance of the company.
  • It is possible that external factors, such as broader market conditions or specific company-related news not mentioned in recent updates, contributed to the bearish movement in HCA's stock price today.

27.00.2026 - HCA Stock was up 6.5%

  • Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst projections and resulting in a bullish trend in its stock price.
  • Investor enthusiasm was fueled by the company's announcement of a new $10 billion share repurchase plan and an uptick in the quarterly dividend.
  • Despite a slight miss in revenue expectations for Q4, HCA Healthcare's focus on profitability, sustained EPS growth, and ambitious financial objectives for 2026 provided a favorable perspective for investors.
  • Confidence in HCA Healthcare's performance and future prospects was bolstered by Markel Group Inc.'s increased stake and the overall positive sentiment from analysts and institutional investors.

27.00.2026 - HCA Stock was up 7.1%

  • Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst expectations and resulting in a bullish movement in the stock.
  • Investor confidence was further boosted by the company's announcement of a new $10 billion share repurchase program and an increased quarterly dividend.
  • Despite a cautious revenue guidance for 2026, HCA Healthcare's commitment to profitability and continued EPS growth highlighted its ability to effectively navigate a stable operating environment.
  • The positive market sentiment towards HCA Healthcare was evident through increased institutional investments, with entities like Markel Group Inc. acquiring additional shares, indicating a growing confidence in the company's performance and future prospects.

28.00.2026 - HCA Stock was down 5.3%

  • Despite reporting strong Q4 earnings, HCA Healthcare's stock experienced a bearish movement as the cautious revenue guidance for 2026 fell below analyst expectations.
  • The announcement of a new $10 billion share repurchase program and an increased quarterly dividend were not enough to offset concerns about the company's future revenue growth.
  • The market may be reacting negatively to economic headwinds, which could impact HCA's revenue projections for the upcoming year.
  • The bullish sentiment on outpatient expansion might not have been sufficient to reassure investors about the company's overall growth prospects, leading to the bearish movement in the stock price.

22.06.2025 - HCA Stock was down 0.6%

  • The bearish movement in HCA stock today could be attributed to the lack of optimistic expectations for its upcoming Q2 earnings:
  • Analysts are cautious about the potential for an earnings beat, as the company may not possess the right combination of key ingredients.
  • Investors might be adjusting their positions in anticipation of underwhelming performance in key metrics for the quarter ended June 2025.
  • The market sentiment seems to be influenced by the uncertainty surrounding HCA Healthcare's earnings growth prospects, leading to a downward pressure on the stock price.

11.01.2026 - HCA Stock was up 5.0%

  • The reduction in stake by Prospera Financial Services Inc. did not deter other institutional investors like Norges Bank and Viking Global Investors LP from increasing their positions in HCA, indicating confidence in the company's growth prospects.
  • HCA's robust financial performance, beating EPS estimates, issuing optimistic guidance, and raising its dividend, likely contributed to the bullish movement in its stock price.
  • The upcoming community meetings regarding HCA Mission Health System may have also generated positive sentiment among investors, showcasing transparency and accountability in the company's operations.
  • HCA's strategic focus on expanding market presence, enhancing digital capabilities, and managing risks highlighted in its SEC 10-K report further solidifies investor confidence in the company's long-term sustainability and growth potential.

24.09.2025 - HCA Stock was up 2.4%

  • HCA Healthcare (HCA) exceeded expectations in Q3 earnings and revenues, reflecting a strong performance during the last quarter.
  • Analysts adjusted their forecasts for HCA Healthcare before the earnings announcement, expecting a rise in quarterly earnings per share.
  • With a track record of outperforming the market over the past decade, HCA Healthcare has consistently delivered returns to its investors.
  • Despite concerns about rising costs affecting Q3 earnings, the company's robust revenue growth has fueled a bullish trend in its stock.

11.01.2026 - HCA Stock was up 6.6%

  • Unusual options activity on HCA Healthcare, with predominantly bullish trades and a price window of $350.0 to $560.0, signals a positive sentiment among investors, propelling the stock price higher.
  • The reduction in stake by Prospera Financial Services Inc. may have initially raised concerns, but increased positions by other institutional investors and robust quarterly earnings report surpassing EPS estimates and raising dividends have reassured investors and fueled the bullish trend.
  • The upcoming community meetings to discuss updates on HCA Mission Health System could be viewed as a favorable move towards transparency and accountability, potentially enhancing investor confidence in HCA Healthcare's operations and future outlook.

24.10.2025 - HCA Stock was down 1.9%

  • The bearish movement in HCA stock today could be due to concerns about increased competition and potential market share loss following Teladoc's aggressive acquisition strategy in the healthcare industry.
  • Investors might be worried that Teladoc's expanding global footprint and growth across key segments could pose a threat to HCA's market position and profitability.
  • The market might be reacting to the perceived long-term impact of Teladoc's strategic moves on HCA's business prospects, leading to a sell-off of HCA shares in today's trading session.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.